RD
Ryan Deschner Raymond James Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
37%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Strong Buy
Upgraded
| $143 |
5%
upside
| 2 | +93% |
0
%
| 19 Nov ‘25 3 months ago |
|
|
|
Market Perform
Downgraded
| – | – | 2 | -76% |
0
%
| 14 Oct ‘25 4 months ago |
|
|
|
Strong Buy
Maintained
| $41 |
14%
upside
| 2 | +53% |
0
%
| 13 Aug ‘25 6 months ago |
|
|
|
Strong Buy
Maintained
| $27 |
131%
upside
| 2 | +65% |
0
%
| 8 Aug ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $12 |
94%
upside
| 1 | +41% |
0
%
| 5 Aug ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $50 |
150%
upside
| 2 | +7.5% |
0
%
| 1 Aug ‘25 7 months ago |
|
|
|
Strong Buy
Maintained
| $122 |
263%
upside
| 1 | +0.63% |
0
%
| 24 Jul ‘25 7 months ago |
|
|
|
Hold
Downgraded
| $4 |
0%
upside
| 2 | +34% |
0
%
| 16 May ‘25 9 months ago |
|